Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion

NeuroImmunoModulation

Volumn 20, Issue 6, 2013, Pages 341-347

  Rotondi, Mario ^a   Batocchi, Anna Paola ^b   Coperchini, Francesca ^a   Caggiula, Marcella ^c   Zerbini, Francesca ^a   Sideri, Riccardo ^a   Leporati, Paola ^a   Nociti, Viviana ^d   Frisullo, Giovanni ^b   Mirabella, Massimiliano ^b   Magri, Flavia ^a   Oliviero, Antonio ^e   Chiovato, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c VITO FAZZI HOSPITAL   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^e HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

Body mass index; Disability; Leptin; Multiple sclerosis

Indexed keywords

LEPTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN SECRETION;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; DISABILITY EVALUATION; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84885091011     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000353567     Document Type: Article

References (28)

1. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
2. Conde J, Scotece M, Gómez R, Gómez-Reino JJ, Lago F, Gualillo O: At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol 2010; 6: 801-808.
3. Fantuzzi G, Faggioni R: Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-446.
4. La Cava A, Matarese G: The weight of leptin in immunity. Nat Rev Immunol 2004; 4: 371-379.
5. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901.
6. Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW: Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum 2005; 64: 1195-1198.
7. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM: Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65.
8. Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S: Balancing susceptibility to infection and autoimmunity: a role for leptin Trends Immunol 2002; 23: 182-187.
9. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ, Ross RJ: High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001; 167: 4593-4599.
10. Batra A, Okur B, Glauben R, Erben U, Ihbe J, Stroh T, Fedke I, Chang HD, Zeitz M, Siegmund B: Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. Endocrinology 2010; 151: 56-62.
11. Galgani M, Procaccini C, De Rosa V, Carbone F, Chieffi P, La Cava A, Matarese G: Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J Immunol 2010; 185: 7474-7479.
12. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S: Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001; 166: 5909-5916.
13. Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR, Lechler RI, Fontana S, Zappacosta S: Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol 2001; 31: 1324-1332.
14. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, Matarese G: Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 2003; 111: 241-250.
15. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH: T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010; 162: 1-11.
16. Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S: Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci USA 2005; 102: 5150-5155.
17. Matarese G, Procaccini C, De Rosa V: The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis J Leukoc Biol 2008; 84: 893-899.
18. Matarese G, Carrieri PB, Montella S, De Rosa V, La Cava A: Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol 2010; 6: 455-461.
19. Frisullo G, Mirabella M, Angelucci F, Caggiula M, Morosetti R, Sancricca C, Patanella AK, Nociti V, Iorio R, Bianco A, Tomassini V, Pozzilli C, Tonali PA, Matarese G, Batocchi AP: The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007; 192: 174-183.
20. Batocchi AP, Rotondi M, Caggiula M, Frisullo G, Odoardi F, Nociti V, Carella C, Tonali PA, Mirabella M: Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003; 139: 150-154.
21. Chatzanton K, Papathanassopoulos P, Gourzoulidou E, Mouzaki A: Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS). In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients. J Autoimmun 2004; 23: 169-177.
22. Hietaharju A, Kuusisto H, Nieminen R, Vuolteenaho K, Elovaara I, Moilanen E: Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. Eur J Neurol 2010; 17: 332-334.
23. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
24. Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A: Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One 2013; 8:e54615.
25. Isidori AM, Strollo F, Morè M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A: Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000; 85: 1954-1962.
26. Gómez JM, Maravall FJ, Gómez N, Navarro MA, Casamitjana R, Soler J: Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol 2003; 58: 213-219.
27. Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K: Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 2542-2547.
28. De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G: A key role of leptin in the control of regultory T cell proliferation. Immunity 2007; 26: 241-255.